Phase I PK study of budesonide/albuterol delivered from PT027 in healthy Chinese participants.

Trial Identifier: D6935C00001
Sponsor: AstraZeneca
Start Date: August 2024
Primary Completion Date: September 2024
Study Completion Date: September 2024
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
CN Shanghai, CN, 200031